Phibro Animal Health (PAHC) Capital Expenditures Growth (5y) (2018 - 2026)
Phibro Animal Health (PAHC) Capital Expenditures Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.21 Bn | 1.97 Bn |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.06 Bn | 20.91 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.25 Bn | 18.44 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.48 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Phibro Animal Health | 1.42 Bn | 1.34 Bn | 125.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.79% |
| Dec 31, 2025 | 142.65% |
| Sep 30, 2025 | -12.52% |
| Jun 30, 2025 | -16.65% |
| Mar 31, 2025 | 212.90% |
| Dec 31, 2024 | 26.55% |
| Sep 30, 2024 | 4.54% |
| Jun 30, 2024 | -15.16% |
| Mar 31, 2024 | 57.22% |
| Dec 31, 2023 | 107.92% |
| Sep 30, 2023 | 20.25% |
| Jun 30, 2023 | 14.52% |
| Mar 31, 2023 | 25.11% |
| Dec 31, 2022 | -33.72% |
| Sep 30, 2022 | 35.91% |
| Jun 30, 2022 | -9.86% |
| Mar 31, 2022 | -7.59% |
| Dec 31, 2021 | 55.06% |
| Sep 30, 2021 | 88.07% |
| Jun 30, 2021 | -44.29% |